120 related articles for article (PubMed ID: 8280369)
1. Effect of gastrin-releasing peptide on the pancreatic tumor cell line (Capan).
Avis I; Jett M; Kasprzyk PG; Cuttitta F; Treston AM; Maneckjee R; Mulshine JL
Mol Carcinog; 1993; 8(4):214-20. PubMed ID: 8280369
[TBL] [Abstract][Full Text] [Related]
2. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
3. Effect of the gastrin-releasing peptide antagonist BIM 26226 and lanreotide on an acinar pancreatic carcinoma.
Damgé C; Hajri A
Eur J Pharmacol; 1998 Apr; 347(1):77-86. PubMed ID: 9650851
[TBL] [Abstract][Full Text] [Related]
4. Gastrin-releasing peptide: in vivo and in vitro growth effects on an acinar pancreatic carcinoma.
Hajri A; Balboni G; Koenig M; Garaud JC; Damgé C
Cancer Res; 1992 Jul; 52(13):3726-32. PubMed ID: 1319829
[TBL] [Abstract][Full Text] [Related]
5. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
Reile H; Armatis PE; Schally AV
Prostate; 1994 Jul; 25(1):29-38. PubMed ID: 8022709
[TBL] [Abstract][Full Text] [Related]
6. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
Narayan S; Guo YS; Townsend CM; Singh P
Cancer Res; 1990 Nov; 50(21):6772-8. PubMed ID: 2208141
[TBL] [Abstract][Full Text] [Related]
7. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors.
Qin Y; Halmos G; Cai RZ; Szoke B; Ertl T; Schally AV
J Cancer Res Clin Oncol; 1994; 120(9):519-28. PubMed ID: 8045917
[TBL] [Abstract][Full Text] [Related]
8. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
Siegfried JM; Krishnamachary N; Gaither Davis A; Gubish C; Hunt JD; Shriver SP
Pulm Pharmacol Ther; 1999; 12(5):291-302. PubMed ID: 10545285
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the murine pancreatic receptor for gastrin releasing peptide and bombesin.
Fanger BO; Wade AC; Cardin AD
Regul Pept; 1991 Feb; 32(3):241-51. PubMed ID: 1650953
[TBL] [Abstract][Full Text] [Related]
10. Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus.
Leban JJ; Kull FC; Landavazo A; Stockstill B; McDermed JD
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1922-6. PubMed ID: 8446610
[TBL] [Abstract][Full Text] [Related]
11. Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters.
Szepeshazi K; Schally AV; Groot K; Halmos G
Int J Cancer; 1993 May; 54(2):282-9. PubMed ID: 8387464
[TBL] [Abstract][Full Text] [Related]
12. Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.
Aguayo SM; Miller Y; Boose D; Holley M; Portanova LB; Schuyler KD; Kane MA
Cell Growth Differ; 1996 May; 7(5):563-72. PubMed ID: 8732666
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor.
Patel O; Dumesny C; Giraud AS; Baldwin GS; Shulkes A
Biochem Pharmacol; 2004 Dec; 68(11):2129-42. PubMed ID: 15498503
[TBL] [Abstract][Full Text] [Related]
14. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
Narayan S; Spindel ER; Rubin NH; Singh P
Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
[TBL] [Abstract][Full Text] [Related]
15. High-affinity receptors for peptides of the bombesin family in Swiss 3T3 cells.
Zachary I; Rozengurt E
Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7616-20. PubMed ID: 2999772
[TBL] [Abstract][Full Text] [Related]
16. Carboxyl-terminal modification of a gastrin releasing peptide derivative generates potent antagonists.
Heimbrook DC; Saari WS; Balishin NL; Friedman A; Moore KS; Reimen MW; Kiefer DM; Rotberg NS; Wallen JW; Oliff A
J Biol Chem; 1989 Jul; 264(19):11258-62. PubMed ID: 2544588
[TBL] [Abstract][Full Text] [Related]
17. Bombesin receptors in a human duodenal tumor cell line: binding properties and function.
Williams BY; Schonbrunn A
Cancer Res; 1994 Feb; 54(3):818-24. PubMed ID: 8306345
[TBL] [Abstract][Full Text] [Related]
18. Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells.
Giacchetti S; Gauvillé C; de Crémoux P; Bertin L; Berthon P; Abita JP; Cuttitta F; Calvo F
Int J Cancer; 1990 Aug; 46(2):293-8. PubMed ID: 2166713
[TBL] [Abstract][Full Text] [Related]
19. Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP.
Qin Y; Ertl T; Cai RZ; Horvàth JE; Groot K; Schally AV
Int J Cancer; 1995 Oct; 63(2):257-62. PubMed ID: 7591214
[TBL] [Abstract][Full Text] [Related]
20. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
Halmos G; Schally AV
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
